BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16235238)

  • 1. Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometry.
    Yan Z; Maher N; Torres R; Caldwell GW; Huebert N
    Rapid Commun Mass Spectrom; 2005; 19(22):3322-30. PubMed ID: 16235238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature.
    Yan Z; Caldwell GW
    Anal Chem; 2004 Dec; 76(23):6835-47. PubMed ID: 15571331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites.
    Mutlib A; Lam W; Atherton J; Chen H; Galatsis P; Stolle W
    Rapid Commun Mass Spectrom; 2005; 19(23):3482-92. PubMed ID: 16261644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unbiased high-throughput screening of reactive metabolites on the linear ion trap mass spectrometer using polarity switch and mass tag triggered data-dependent acquisition.
    Yan Z; Caldwell GW; Maher N
    Anal Chem; 2008 Aug; 80(16):6410-22. PubMed ID: 18642850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved detection of reactive metabolites with a bromine-containing glutathione analog using mass defect and isotope pattern matching.
    Leblanc A; Shiao TC; Roy R; Sleno L
    Rapid Commun Mass Spectrom; 2010 May; 24(9):1241-50. PubMed ID: 20391594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.
    Rousu T; Pelkonen O; Tolonen A
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):843-55. PubMed ID: 19224530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.
    Lim HK; Chen J; Cook K; Sensenhauser C; Silva J; Evans DC
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1295-311. PubMed ID: 18383206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering.
    Zhu M; Ma L; Zhang H; Humphreys WG
    Anal Chem; 2007 Nov; 79(21):8333-41. PubMed ID: 17918967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues.
    Soglia JR; Contillo LG; Kalgutkar AS; Zhao S; Hop CE; Boyd JG; Cole MJ
    Chem Res Toxicol; 2006 Mar; 19(3):480-90. PubMed ID: 16544956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining.
    Ma L; Wen B; Ruan Q; Zhu M
    Chem Res Toxicol; 2008 Jul; 21(7):1477-83. PubMed ID: 18549250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection and characterization of in vitro and urinary N-acetyl-L-cysteine conjugates using quadrupole-linear ion trap mass spectrometry and polarity switching.
    Jian W; Yao M; Zhang D; Zhu M
    Chem Res Toxicol; 2009 Jul; 22(7):1246-55. PubMed ID: 19527004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry.
    Wen B; Ma L; Nelson SD; Zhu M
    Anal Chem; 2008 Mar; 80(5):1788-99. PubMed ID: 18251522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry.
    Zheng J; Ma L; Xin B; Olah T; Humphreys WG; Zhu M
    Chem Res Toxicol; 2007 May; 20(5):757-66. PubMed ID: 17402749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a highly sensitive and selective novel trapping reagent, stable isotope labeled glutathione ethyl ester, for the detection of reactive metabolites.
    Yamaoka T; Kitamura Y
    J Pharmacol Toxicol Methods; 2015; 76():83-95. PubMed ID: 26314789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
    Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
    Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening for glutathione conjugates using stable-isotope labeling and negative electrospray ionization precursor-ion mass spectrometry.
    Liao S; Ewing NP; Boucher B; Materne O; Brummel CL
    Rapid Commun Mass Spectrom; 2012 Mar; 26(6):659-69. PubMed ID: 22328220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.
    Barbara JE; Castro-Perez JM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3029-40. PubMed ID: 21953957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening strategy for the rapid detection of in vitro generated glutathione conjugates using high-performance liquid chromatography and low-resolution mass spectrometry in combination with LightSight software for data processing.
    Ramírez-Molina C; Burton L
    Rapid Commun Mass Spectrom; 2009 Nov; 23(22):3501-12. PubMed ID: 19844970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites.
    Damsten MC; van Vugt-Lussenburg BM; Zeldenthuis T; de Vlieger JS; Commandeur JN; Vermeulen NP
    Chem Biol Interact; 2008 Jan; 171(1):96-107. PubMed ID: 17996858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of an electrochemical method for studying reactive phase-I metabolites: correlation to in vitro drug metabolism.
    Madsen KG; Olsen J; Skonberg C; Hansen SH; Jurva U
    Chem Res Toxicol; 2007 May; 20(5):821-31. PubMed ID: 17447796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.